For healthcare risk adjustment leaders, the current landscape is defined by a paradoxical pressure: they are simultaneously tethered to the ghosts of the past and the demands of the future. As the industry enters a critical late-summer window, leaders find themselves managing a "dual mandate"—simultaneously defending historical diagnostic submissions from years prior while sprinting to finalize the data that will dictate financial solvency for the 2027 calendar year.
This period represents a convergence of administrative complexity and regulatory scrutiny. On one side, health plans are navigating the rigid requirements of CMS Risk Adjustment Data Validation (RADV) audits. On the other, they face the unforgiving September 4 submission deadline, a critical juncture that determines initial risk scores and the subsequent payment flows for 2027.
The Chronology of Conflict: Balancing Historical Defense and Future Accuracy
To understand the current strain on health plans, one must examine the divergent timelines governing their operations.
The Retroactive Burden: PY 2021 and 2020 Audits
The look-back period is defined by the rigid requirements of the PY 2021 RADV audit. Following the CMS directive issued in late May, plans were granted a five-month record retrieval window. For many, the clock is ticking toward a late-October deadline. This process is inherently reactive; the documentation exists, and it is immutable. Plans are tasked with locating clinical evidence that was generated years ago. If the evidence was not captured during the initial encounter, it cannot be manufactured now. This creates an environment of vulnerability where the success of an audit depends entirely on the quality of clinical documentation practices from years past.
The Prospective Race: The September 4 Deadline
While the audit teams are deep in the trenches of historical retrieval, the prospective coding teams are facing a more immediate, high-stakes deadline. September 4 marks the submission cutoff for the 2027 initial risk score run. This window covers the service period of July 2025 through June 2026. Unlike the audit process, which is essentially an exercise in forensic discovery, this submission is an active, strategic endeavor. Every chart finalized and submitted before this date directly influences the revenue trajectory for the 2027 payment year.
The "Fixity" Problem: Why Yesterday’s Charts Demand Today’s Precision
A fundamental reality in the current risk adjustment ecosystem is the concept of "fixity." For the charts currently under audit, the record is fixed. The notes were written, the patient was seen, and the diagnosis was submitted. Nothing a plan does this summer can alter the medical reality of a 2021 encounter.
However, the charts in front of risk adjustment leaders today—those covering the July 2025–June 2026 service period—are still malleable. While the notes themselves cannot be rewritten, the coding of those notes remains under the control of the health plan. This is where the risk resides. Every diagnosis submitted on September 4 is effectively a ticking clock. If a diagnosis is submitted without robust clinical evidence, it will eventually become a liability when CMS inevitably selects those charts for a RADV audit in two or three years.
With the V28 model now fully phased in, the industry has lost the "partial-transition cushion" that once softened the impact of documentation gaps. Today’s rushed, unvalidated submission is, quite simply, tomorrow’s failed audit.
Implications for Workflow: The Failure of Siloed Systems
The compressed nature of these deadlines has exposed a systemic fragility: the reliance on fragmented, siloed workflows. Traditionally, health plans have distributed coding, validation, deletion, and evidence review across multiple vendors and disparate review cycles.
In a standard environment, this process might take months. In the current six-week sprint, however, this model is untenable. It is impossible to fit an internal quality control (QC) cycle, a vendor validation cycle, and a final pre-submission check into a timeline that is closing rapidly. This fragmentation often forces a choice between speed and accuracy—a binary that no health plan can afford to choose.
Leveraging Neuro-Symbolic AI: The RAAPID OnePass Paradigm
To bridge the gap between speed and compliance, innovative organizations are moving away from traditional, sequential workflows in favor of unified, technology-driven solutions like RAAPID OnePass.
Bridging Language and Logic
Unlike traditional Natural Language Processing (NLP) tools that merely identify keywords, RAAPID utilizes Neuro-Symbolic AI. This approach combines advanced language understanding with rule-based clinical reasoning. The system does more than scan for codes; it reads the medical record, links every diagnosis to MEAT (Monitor, Evaluate, Assess, Treat) evidence within the clinician’s note, and attaches the clinical rationale.
The Connected Workflow
By integrating identification, validation, deletion, and evidence mapping into a single, connected workflow, OnePass eliminates the latency associated with handoffs between vendors. Coder validation occurs within the same environment, and audit levels are configurable to meet the specific compliance appetite of the plan. Supported codes are added, and unsupported codes are removed simultaneously. This ensures that the speed required to meet the September 4 deadline does not come at the expense of clinical integrity.
Supporting Data and Industry Benchmarks
The efficacy of modern, AI-integrated risk adjustment is not merely anecdotal. RAAPID’s Neuro-Symbolic AI has demonstrated a 92% AI-only coding accuracy rate in independent validations. When supplemented with a single coder review—a process enabled by the OnePass workflow—accuracy rates climb to over 98%.
Furthermore, the value of these systems is reflected in the market’s response. In the May 2026 Emerging Company Spotlight by KLAS Research, RAAPID customers highlighted workflow efficiency at scale as a primary driver for platform adoption. The ability to attach a MEAT-backed evidence trail to every submission is not just a benefit; it is a defensive strategy. It ensures that when a future RADV notice arrives, the five-month record window becomes a matter of document retrieval rather than a desperate, multi-year attempt to reconstruct a clinical narrative that was never properly documented in the first place.
The Path Forward: Strategic Recommendations
As the September 4 deadline approaches, risk adjustment leaders should consider the following strategic imperatives:
- Prioritize Evidence over Volume: The temptation to maximize submission volume is high, but the cost of an audit failure is higher. Every submitted code must carry a clear, defensible trail of evidence that meets current regulatory standards.
- Audit the Workflow, Not Just the Codes: If your current process requires multiple vendor handoffs, you are inherently at risk of missing the September 4 cutoff or sacrificing quality. Evaluate your internal QC cycles for bottlenecks that can be eliminated through unified technology.
- Prepare for the Long Game: View the current submission not as a singular event, but as the first phase of an audit that will occur years from now. If the evidence isn’t attached to the code at the moment of submission, the chances of successfully defending that diagnosis in a future audit decrease significantly.
Conclusion: The Question of Sustainability
The question for health plans this summer is not how many review cycles were required for yesterday’s charts. It is whether the charts being submitted by September 4 will hold up under the inevitable scrutiny of future regulatory cycles.
The scramble currently being experienced by plans managing PY 2021 audits serves as a stark reminder of the cost of disconnected, reactive workflows. By embracing evidence-backed, unified workflows, risk adjustment leaders can transform their operations from a perpetual state of "damage control" into a proactive engine of compliance and financial stability.
For those looking to stress-test their current capabilities, the RAAPID OnePass Challenge offers an opportunity to re-evaluate the speed and accuracy of their submission process before the clock runs out on the 2027 payment year. The future of risk adjustment is not just in the data we submit, but in the clinical integrity we can prove when the audit notice finally arrives.
